Home » Topics » Disease categories and therapies » Infection

Infection
RSS

New quinolones from Dong Wha with improved Gram-positive activity and high safety

Feb. 17, 1999

Cerus gears up for U.S. phase III trials of platelet pathogen inactivation system

Feb. 17, 1999

New ribose-based antibacterial agents in development at HMR

Feb. 16, 1999

Biota's flu drug gets first approval

Feb. 12, 1999

Abbott makes milestone payments to Aronex for antifungal drug Nyotran

Feb. 12, 1999

Cubist enters agreement with Novartis for antiinfective drug discovery

Feb. 12, 1999

In vitro and in vivo profile of antifungal activity reported for FK-463

Feb. 11, 1999

Renal toxicity of NS-718 and amphotericin B compared in laboratory and animal studies

Feb. 11, 1999

Zeneca patents new class of DNA gyrase-inhibiting antibiotics

Feb. 11, 1999

Biota's inhaled influenza drug recommended for approval in Australia

Feb. 10, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...